Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
Clinical trial NCT04113018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04113018
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2023-06-28
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.